| Patent No. | Patent Title: |
| 8188265 | Method for the isolation of mRNA from formalin fixed, paraffin-em... |
| 8183226 | Myocardial perfusion imaging method |
| 8173619 | Phosphoramidate derivatives of nucleoside compounds for use in th... |
| 8168597 | Method for treating cystic fibrosis |
| 8158607 | Crystalline form of lamivudine |
| 8158775 | Method for detaching protecting group on nucleic acid |
| 8153779 | Nucleotide with an alpha-phosphate mimetic |
| 8148349 | Nucleoside cyclic phosphoramidates for the treatment of RNA-depen... |
| 8148112 | Sugar chain containing 4-position halogenated galactose and appli... |
| 8143234 | Uridine administration improves phosphatide synthesis, synaptic t... |
| 8137937 | Method for bisulfite treatment |
| 8133879 | Myocardial perfusion imaging methods and compositions |
| 8133872 | Use of nicotinic acid adenine dinucleotide phosphate or derivativ... |
| 8133880 | Purine derivatives and methods of use thereof |
| 8133861 | Systemic purine administration: modulating axonal outgrowth of ce... |
| 8124756 | Method of preparing 5′-amino-linker oligonucleotides derivative... |
| 8119779 | Phosphoramidate derivatives |
| 8110676 | Prodrugs activated by RNA-dependent DNA-polymerases |
| 8106183 | Process for preparing an A-adenosine receptor agonist and its pol... |
| 8106029 | Use of Aadenosine receptor agonists |
| 8097267 | Moisture resistant container systems for rapidly bioavailable dos... |
| 8097706 | Methods for preparing capecitabine and beta-anomer-rich trialkyl ... |
| 8097651 | Diclofenac formulations and methods of use |
| 8076310 | Phosphonate nucleosides useful as active ingredients in pharmaceu... |
| 8071568 | Nucleoside aryl phosphoramidates for the treatment of RNA-depende... |
| 8071566 | Methods of coronary imaging |
| 8067580 | Isolation of DNA, RNA and protein from a single sample |
| 8058260 | 2′-C-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical com... |
| 8053212 | Non-standard nucleoside analogs with reduced epimerization |
| 8039614 | 4' -C-substituted-2-haloadenosine derivative |
| 8039612 | Synthesis of oligonucleotides or phosphorothioate oligonucleotide... |
| 8039613 | Methods of purifying a nucleic acid and formulation and kit for u... |
| 8030293 | Methods of optimizing drug therapeutic efficacy for treatment of ... |
| 8026348 | Nucleoside derivative, modified oligonucleotide, method for their... |
| 8008476 | Room temperature stable agarose solutions |
| 8008007 | S-adenosyl-L-methionine analogs with extended activated groups fo... |
| 7998706 | Propargyl substituted nucleoside compounds and methods |
| 7999099 | Modified 5′-phosphonate azidothymidine—potential anti-viral p... |
| 7994310 | Process for preparing 2′-deoxy-2′, 2′-difluorocytidine |
| 7994140 | Classes of compounds that interact with GPCRs |
Quotables 
PatentStorm News
